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chemotherapy was performed in only one case. Postoperative
adjuvant radiation therapy (n = 29), postoperative radiation
and chemotherapy (n = 9), and chemotherapy alone (n = 4)
had no influence on survival. We recorded surgical proce-
dures, pathologic findings, N status (as reviewed in 19974),
survival, and long-term results, as well as the cause of death.
The Kaplan-Meier method was used to estimate survival.
Results. During exploratory thoracotomy, 3 patients were
deemed to have unresectable disease, and 6 patients under-
went an incomplete resection. A complete resection of macro-
scopic disease was performed in 59 patients (lobectomy, n =
28; bilobectomy, n = 11; and pneumonectomy, n = 20). The
diaphragm was resected en bloc with the tumor in all cases
(primary closure, n = 55; reconstruction with a prosthesis, n =
4). The mediastinal lymph node dissection was complete in 39
patients, incomplete in 13 patients (limited to adjacent medi-
astinal lymph nodes), and not performed at all in 7 patients
(pN status in Table I). There were 35 squamous cell carcino-
mas, 16 adenocarcinomas, 1 adenosquamous carcinoma, 3
large cell carcinomas, 1 undifferentiated neuroendocrine car-
cinoma, and 1 sarcomatoid carcinoma; histologic pathology
was not available in 2 patients. The tumor was adherent to the
diaphragm without histologic invasion in 13 patients, and it
pathologically invaded the diaphragm in 41 patients (pleural
serosa, n = 6; muscle, n = 32; and peritoneum, n = 4). Such
data were not available in 4 patients. pN status between
groups with or without histologic diaphragm invasion was not
significantly different.
There were 3 postoperative deaths (sepsis, n = 1; pneu-
mopathy, n = 2) and 10 postoperative complications (pleu-
roparietal sepsis, n = 5; fistula, n = 1; pneumopathy, n = 1;
prolonged air leak, n = 1; respiratory failure, n = 1; and intesti-
nal obstruction, n = 1). There was no survival beyond 2 years
in case of unresected or incompletely resected disease. There
was no survival beyond 5 years when mediastinal lymph node
dissection was not performed, and there was only one survival
at 5 years when mediastinal lymph node dissection was
incomplete. The overall 5-year survival was 39% (confidence
interval, 30%-48%) in case of complete mediastinal lymph
node dissection. Prognosis was not influenced by the degree
of pathologic invasion of the diaphragm. Prognosis appeared
as bad in N0 cases as in N1 and N2 cases. N+ involvement
proved to be very frequent (67%; N1 = 23% and N2 = 44%;
Table I). Causes of death (n = 35) are summarized in Table II.
Twenty-four patients were still alive, but only 16 (67%) were
free of disease.
Discussion. The poor prognosis of this entity was obvious
in this series. The attribution by Doyle and Aisner3 of such a
Non–small cell lung cancer (NSCLC) invading the
diaphragm is a rare stage III disease with a poor prognosis. In
1997, Weksler and associates1 reported the only study con-
cerning its surgical management, observing 8 cases among
4688 patients undergoing exploration for resection of
NSCLC. In 1998, Inoue and colleagues2 reported 5 other
cases and suggested that such NSCLC invading the
diaphragm may be a candidate of the T4 TNM subgroup.
Doyle and Aisner3 attributed such a bad prognosis to the
extensive venous and lymphatic drainage from the diaphragm
that almost invariably results in disease outside the scope of
surgery, further explaining that “once cancer cells have
crossed both the visceral and parietal layers of pleura into
diaphragmatic muscle, there is almost always invasion of the
liver or metastases to the retroperitoneal lymph nodes or
both.” For this entity to be further evaluated and explained, the
examination of a larger number of cases was mandatory. This
was the purpose of this retrospective multicentric study.
Patients and methods. We retrospectively reviewed the
cases of 68 patients who had exploratory thoracotomy for
resection of NSCLC invading the diaphragm. These patients
were operated on in 17 different centers from February 1976
to February 1998. There were 56 men and 12 women. The
mean age was 61 years (range, 35-85 years); 22 tumors were
on the left, and 46 were on the right. All patients were free of
clinical metastatic disease, as determined by chest computed
tomography (CT), brain CT, abdominal CT, or ultrasonogra-
phy. Mediastinoscopy was not routinely performed. Induction
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bad prognosis to the extensive venous and lymphatic drainage
from the diaphragm is well demonstrated by this review,
revealing the high frequency of lymph node involvement and
deaths caused by systemic metastases. The lymphatic
involvement mainly spread upward along the anatomic vis-
ceral lymphatic pathways of the mediastinum, as shown by
the high frequency of N2 disease revealed by mediastinal
lymph node dissection and further characterized by a high
frequency of involvement of 2 or more anatomic mediastinal
levels (65%). The current frequency of such involvement
appeared to be only 39% in a population with resected N2
lung cancer.5 The lymphatic drainage of the diaphragm prob-
ably constitutes a pathway for the tumor cells to join the
blood circulation through the mediastinum, and this may
explain the poor prognosis we observed even in cases of N0
and N1 disease; the 5 cases that prompted Inoue and col-
leagues2 to suggest labeling the diaphragm invasion as T4
were also N0 and N1. To conclude, this review confirms that
diaphragm invasion is an advanced stage and therefore is a
potential indication for neoadjuvant chemotherapy, as sug-
gested by Weksler and associates.1 Because diaphragm inva-
sion is clinically difficult to assess,1 we suggest performing
video-assisted thoracoscopy for pretreatment T staging to
complement mediastinoscopy in cases of cancer with close
contact with the diaphragm. On the other hand, this entity
may benefit from adjuvant chemotherapy if discovered after
surgery.
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Table I. pN status of completely resected cancers
MLND N0 N1 N2 (1) N2 (2)
Complete 39 13 9 6 11
Incomplete 13 7 4 1 1
Not performed 7 5 2
Total 59 25 15 7 12
MLND, Mediastinal lymph node dissection; N2 (1), 1 anatomic level involved;
N2 (2), 2 or more anatomic levels involved.4,5
Table II. Causes of deaths (n = 35) in cases of com-
pletely resected cancer (n = 59)
Causes of death N0 N1 N2 Total
Postoperative 2 1 3
Metastases 6 4 8 18
Metastases + local recurrence 3 3
Local recurrence alone 4 1 5
Other cancer 1 1 2
Cancer unrelated 2 1 1 4
Total 16 9 10 35
